Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchMetforminMetformin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Does the Consumption of Metformin Correlate With a Reduction in Mortality Among Patients With Type 2 Diabetes and COVID-19 in Morocco?

Benfathallah et al., Cureus, doi:10.7759/cureus.77288
Jan 2025  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 54% Improvement Relative Risk Metformin  Benfathallah et al.  Prophylaxis Is prophylaxis with metformin beneficial for COVID-19? Retrospective 115 patients in Morocco (August 2020 - August 2021) Lower mortality with metformin (p=0.041) c19early.org Benfathallah et al., Cureus, January 2025 Favorsmetformin Favorscontrol 0 0.5 1 1.5 2+
Metformin for COVID-19
3rd treatment shown to reduce risk in July 2020, now with p < 0.00000000001 from 102 studies.
No treatment is 100% effective. Protocols combine treatments.
5,200+ studies for 112 treatments. c19early.org
Retrospective 115 hospitalized type 2 diabetes patients in Morocco showing significantly lower mortality with metformin use.
risk of death, 53.6% lower, RR 0.46, p = 0.04, treatment 8 of 41 (19.5%), control 30 of 74 (40.5%), NNT 4.8, adjusted per study, odds ratio converted to relative risk, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Benfathallah et al., 11 Jan 2025, retrospective, Morocco, peer-reviewed, mean age 65.5, 5 authors, study period 1 August, 2020 - 1 August, 2021. Contact: bouchra_benfathallah@um5.ac.ma.
This PaperMetforminAll
Does the Consumption of Metformin Correlate With a Reduction in Mortality Among Patients With Type 2 Diabetes and COVID-19 in Morocco?
Bouchra Benfathallah, Abha Cherkani Hassani, Samia El Hilali, Redouane Abouqal, Laïla Benchekroun
Cureus, doi:10.7759/cureus.77288
Objectives: To assess whether metformin therapy for type 2 diabetes (T2DM) was associated with a reduced mortality rate in patients hospitalized for COVID-19 compared to other antihyperglycemic drugs. Methods: This retrospective study included patients with T2DM who tested positive for SARS-CoV-2 between 1 August 2020 and 1 August 2021. The patients were required to be aged over 18 years old and to be undergoing treatment for hyperglycemia, whether with metformin, other oral antidiabetic drugs, or insulin. A data exploitation sheet was completed for each patient. The Jamovi ( https://www.jamovi.org/ ) software was applied to conduct the statistical analyses. Multivariate logistic regression was used to determine whether metformin use was associated with reduced mortality among patients with T2DM and COVID-19. Results: We identified 115 COVID-19 patients with T2DM, of whom 41 were on metformin, 35 patients were on insulin, and 39 patients were on other oral antihyperglycemic agents; the average age of patients was 65.5±13.2 years, and 52.2% were male. The mortality rate was lower in the metformin user group (21.1%) compared to the non-user group (78.9%). The multivariate logistic regression model indicated that age (OR=1.06; 95% CI (1.02-1.10); p=0.002) and glycemia (OR=1.49; 95% CI (1.05-2.11); p=0.024) were significantly associated with mortality in patients with T2DM and COVID-19. Whereas, the use of metformin was identified as a protective factor (OR=0.34 95% CI (0.12-0.95); p=0.041). Conclusion: This study highlighted that metformin seems to be associated with significantly decreased mortality in adults with T2DM and COVID-19.
Additional Information Author Contributions All authors have reviewed the final version to be published and agreed to be accountable for all aspects of the work. Concept and design: Bouchra Benfathallah, Abha Cherkani Hassani , Redouane Abouqal, Laïla Benchekroun Acquisition, analysis, or interpretation of data: Bouchra Benfathallah, Abha Cherkani Hassani , Samia El Hilali, Redouane Abouqal, Laïla Benchekroun Drafting of the manuscript: Bouchra Benfathallah, Laïla Benchekroun Critical review of the manuscript for important intellectual content: Bouchra Benfathallah, Abha Cherkani Hassani , Samia El Hilali, Redouane Abouqal, Laïla Benchekroun Supervision: Bouchra Benfathallah, Abha Cherkani Hassani , Samia El Hilali, Redouane Abouqal, Laïla Benchekroun Disclosures Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. The Ethics Committee of Biomedical Research (CERB) issued approval N/R: Dossier n°L/21. Data access and patient anonymity were respected according to national and international guidelines. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they..
References
Bornstein, Rubino, Khunti, Practical recommendations for the management of diabetes in patients with COVID-19, Lancet Diabetes Endocrinol, doi:10.1016/S2213-8587(20)30152-2
Bramante, Huling, Tignanelli, Randomized trial of metformin, ivermectin, and fluvoxamine for COVID-19, N Engl J Med, doi:10.1056/NEJMoa2201662
Bramante, Ingraham, Murray, Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis, Lancet Healthy Longev, doi:10.1016/S2666-7568(20)30033-7
Cao, Baranova, Wei, Wang, Zhang, Bidirectional causal associations between type 2 diabetes and COVID-19, J Med Virol, doi:10.1002/jmv.28100
Cao, Li, Tao, Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway, Endocrinol, doi:10.1210/en.2013-1002
Cheng, Xin, Chen, Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: a multicentral retrospective study, Life Sci, doi:10.1016/j.lfs.2021.119371
Erickson, Fenno, Barzilai, Metformin for treatment of acute COVID-19: systematic review of clinical trial data against SARS-CoV-2, Diabetes Care, doi:10.2337/dc22-2539
Fang, Karakiulakis, Roth, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, doi:10.1016/S2213-2600(20)30116-8
Gallo Marin, Aghagoli, Lavine, Predictors of COVID-19 severity: a literature review, Rev Med Virol, doi:10.1002/rmv.2146
Gao, Liu, Zhong, Liu, Zhou et al., Risk of metformin in patients with type 2 diabetes with COVID-19: a preliminary retrospective report, Clin Transl Sci, doi:10.1111/cts.12897
Ghany, Palacio, Dawkins, Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA, Diabetes Metab Syndr, doi:10.1016/j.dsx.2021.02.022
Hariyanto, Kurniawan, Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection, Obes Med, doi:10.1016/j.obmed.2020.100290
Holman, Knighton, Kar, Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study, Lancet Diabetes Endocrinol, doi:10.1016/S2213-8587(20)30271-0
Kaneto, Kimura, Obata, Shimoda, Kaku, Multifaceted mechanisms of action of metformin which have been unraveled one after another in the long history, Int J Mol Sci, doi:10.3390/ijms22052596
Lalau, Al-Salameh, Hadjadj, Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19, Diabetes Metab, doi:10.1016/j.diabet.2020.101216
Li, Yang, Yan, Sun, Zeng et al., Metformin in patients with COVID-19: a systematic review and meta-analysis, Front Med, doi:10.3389/fmed.2021.704666
Lukito, Pranata, Henrina, Lim, Lawrensia et al., The effect of metformin consumption on mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis, Diabetes Metab Syndr, doi:10.1016/j.dsx.2020.11.006
Luo, Qiu, Liu, Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis, Am J Trop Med Hyg, doi:10.4269/ajtmh.20-0375
Ma, Krishnamurthy, Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis, PLoS One, doi:10.1371/journal.pone.0282210
Malhotra, Hepokoski, Mccowen, Shyy, ACE2, metformin, and COVID-19, Iscience
Samuel, Varghese, Büsselberg, Therapeutic potential of metformin in COVID-19: reasoning for its protective role, Trends Microbiol, doi:10.1016/j.tim.2021.03.004
Sharma, Ray, Sadasivam, Metformin in COVID-19: a possible role beyond diabetes, Diabetes Res Clin Pract, doi:10.1016/j.diabres.2020.108183
Silverii, Fumagalli, Rozzini, Milani, Mannucci et al., Is metformin use associated with a more favorable Covid-19 course in people with diabetes?, J Clin Med, doi:10.3390/jcm13071874
Singh, Singh, Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?, Diabetes Res Clin Pract, doi:10.1016/j.diabres.2020.108268
Song, Zhang, Meng, Mechanism and application of metformin in kidney diseases: an update, Biomed Pharmacother, doi:10.1016/j.biopha.2021.111454
Tong, Grant, Gras, The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes, FEBS J, doi:10.1111/febs.16105
Wang, Cooper, Gokhale, Association of metformin with susceptibility to COVID-19 in people with type 2 diabetes, J Clin Endocrinol Metab, doi:10.1210/clinem/dgab067
Wang, Lin, Sy, Renal protective effect of metformin in type 2 diabetes patients, J Clin Endocrinol Metab, doi:10.1210/clinem/dgae477
Watson, Dhaliwal, Robertshaw, Consensus recommendations for sick day medication guidance for people with diabetes, kidney, or cardiovascular disease: a modified Delphi process, Am J Kidney Dis, doi:10.1053/j.ajkd.2022.10.012
Wiernsperger, Al-Salameh, Cariou, Lalau, Protection by metformin against severe COVID-19: an in-depth mechanistic analysis, Diabetes Metab, doi:10.1016/j.diabet.2022.101359
Zumla, Hui, Azhar, Memish, Maeurer, Reducing mortality from 2019-nCoV: host-directed therapies should be an option, Lancet, doi:10.1016/S0140-6736(20)30305-6
{ 'indexed': { 'date-parts': [[2025, 1, 12]], 'date-time': '2025-01-12T05:21:46Z', 'timestamp': 1736659306657, 'version': '3.32.0'}, 'reference-count': 31, 'publisher': 'Springer Science and Business Media LLC', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2025, 1, 11]]}, 'DOI': '10.7759/cureus.77288', 'type': 'journal-article', 'created': {'date-parts': [[2025, 1, 11]], 'date-time': '2025-01-11T17:55:46Z', 'timestamp': 1736618146000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Does the Consumption of Metformin Correlate With a Reduction in Mortality Among Patients With ' 'Type 2 Diabetes and COVID-19 in Morocco?', 'prefix': '10.7759', 'author': [ {'given': 'Bouchra', 'family': 'Benfathallah', 'sequence': 'first', 'affiliation': []}, {'given': 'Abha', 'family': 'Cherkani Hassani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Samia', 'family': 'El Hilali', 'sequence': 'additional', 'affiliation': []}, {'given': 'Redouane', 'family': 'Abouqal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laïla', 'family': 'Benchekroun', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'reference': [ { 'key': 'ref1', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/febs.16105', 'article-title': 'The role of T-cell immunity in COVID-19 severity amongst people living ' 'with type II diabetes', 'volume': '288', 'author': 'Tong ZW', 'year': '2021', 'unstructured': 'Tong ZW, Grant E, Gras S, et al.. The role of T-cell immunity in ' 'COVID-19 severity amongst people living with type II diabetes. FEBS J. ' '2021, 288:5042-54. 10.1111/febs.16105', 'journal-title': 'FEBS J'}, { 'key': 'ref2', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S2213-8587(20)30271-0', 'article-title': 'Risk factors for COVID-19-related mortality in people with type 1 and ' 'type 2 diabetes in England: a population-based cohort study', 'volume': '8', 'author': 'Holman N', 'year': '2020', 'unstructured': 'Holman N, Knighton P, Kar P, et al.. Risk factors for COVID-19-related ' 'mortality in people with type 1 and type 2 diabetes in England: a ' 'population-based cohort study. Lancet Diabetes Endocrinol. 2020, ' '8:823-33. 10.1016/S2213-8587(20)30271-0', 'journal-title': 'Lancet Diabetes Endocrinol'}, { 'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S2213-2600(20)30116-8', 'article-title': 'Are patients with hypertension and diabetes mellitus at increased risk ' 'for COVID-19 infection?', 'volume': '8', 'author': 'Fang L', 'year': '2020', 'unstructured': 'Fang L, Karakiulakis G, Roth M. Are patients with hypertension and ' 'diabetes mellitus at increased risk for COVID-19 infection?. Lancet ' 'Respir Med. 2020, 8:e21. 10.1016/S2213-2600(20)30116-8', 'journal-title': 'Lancet Respir Med'}, { 'key': 'ref4', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.28100', 'article-title': 'Bidirectional causal associations between type 2 diabetes and COVID-19', 'volume': '95', 'author': 'Cao H', 'year': '2023', 'unstructured': 'Cao H, Baranova A, Wei X, Wang C, Zhang F. Bidirectional causal ' 'associations between type 2 diabetes and COVID-19. J Med Virol. 2023, ' '95:e28100. 10.1002/jmv.28100', 'journal-title': 'J Med Virol'}, { 'key': 'ref5', 'doi-asserted-by': 'publisher', 'DOI': '10.1210/clinem/dgab067', 'article-title': 'Association of metformin with susceptibility to COVID-19 in people with ' 'type 2 diabetes', 'volume': '106', 'author': 'Wang J', 'year': '2021', 'unstructured': 'Wang J, Cooper JM, Gokhale K, et al.. Association of metformin with ' 'susceptibility to COVID-19 in people with type 2 diabetes. J Clin ' 'Endocrinol Metab. 2021, 106:1255-68. 10.1210/clinem/dgab067', 'journal-title': 'J Clin Endocrinol Metab'}, { 'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/jcm13071874', 'article-title': 'Is metformin use associated with a more favorable Covid-19 course in ' 'people with diabetes?', 'volume': '13', 'author': 'Silverii GA', 'year': '2024', 'unstructured': 'Silverii GA, Fumagalli C, Rozzini R, Milani M, Mannucci E, Marchionni N. ' 'Is metformin use associated with a more favorable Covid-19 course in ' 'people with diabetes?. J Clin Med. 2024, 13:1874. 10.3390/jcm13071874', 'journal-title': 'J Clin Med'}, { 'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.2337/dc22-2539', 'article-title': 'Metformin for treatment of acute COVID-19: systematic review of ' 'clinical trial data against SARS-CoV-2', 'volume': '46', 'author': 'Erickson SM', 'year': '2023', 'unstructured': 'Erickson SM, Fenno SL, Barzilai N, et al.. Metformin for treatment of ' 'acute COVID-19: systematic review of clinical trial data against ' 'SARS-CoV-2. Diabetes Care. 2023, 46:1432-42. 10.2337/dc22-2539', 'journal-title': 'Diabetes Care'}, { 'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S2666-7568(20)30033-7', 'article-title': 'Metformin and risk of mortality in patients hospitalised with COVID-19: ' 'a retrospective cohort analysis', 'volume': '2', 'author': 'Bramante CT', 'year': '2021', 'unstructured': 'Bramante CT, Ingraham NE, Murray TA, et al.. Metformin and risk of ' 'mortality in patients hospitalised with COVID-19: a retrospective cohort ' 'analysis. Lancet Healthy Longev. 2021, 2:e34-41. ' '10.1016/S2666-7568(20)30033-7', 'journal-title': 'Lancet Healthy Longev'}, { 'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0282210', 'article-title': 'Is metformin use associated with low mortality in patients with type 2 ' 'diabetes mellitus hospitalized for COVID-19? a multivariable and ' 'propensity score-adjusted meta-analysis', 'volume': '18', 'author': 'Ma Z', 'year': '2023', 'unstructured': 'Ma Z, Krishnamurthy M. Is metformin use associated with low mortality in ' 'patients with type 2 diabetes mellitus hospitalized for COVID-19? a ' 'multivariable and propensity score-adjusted meta-analysis. PLoS One. ' '2023, 18:e0282210. 10.1371/journal.pone.0282210', 'journal-title': 'PLoS One'}, { 'key': 'ref10', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fmed.2021.704666', 'article-title': 'Metformin in patients with COVID-19: a systematic review and ' 'meta-analysis', 'volume': '8', 'author': 'Li Y', 'year': '2021', 'unstructured': 'Li Y, Yang X, Yan P, Sun T, Zeng Z, Li S. Metformin in patients with ' 'COVID-19: a systematic review and meta-analysis. Front Med (Lausanne). ' '2021, 8:704666. 10.3389/fmed.2021.704666', 'journal-title': 'Front Med (Lausanne)'}, { 'key': 'ref11', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.diabet.2020.101216', 'article-title': 'Metformin use is associated with a reduced risk of mortality in ' 'patients with diabetes hospitalised for COVID-19', 'volume': '47', 'author': 'Lalau JD', 'year': '2021', 'unstructured': 'Lalau JD, Al-Salameh A, Hadjadj S, et al.. Metformin use is associated ' 'with a reduced risk of mortality in patients with diabetes hospitalised ' 'for COVID-19. Diabetes Metab. 2021, 47:101216. ' '10.1016/j.diabet.2020.101216', 'journal-title': 'Diabetes Metab'}, { 'key': 'ref12', 'doi-asserted-by': 'publisher', 'DOI': '10.4269/ajtmh.20-0375', 'article-title': 'Metformin treatment was associated with decreased mortality in COVID-19 ' 'patients with diabetes in a retrospective analysis', 'volume': '103', 'author': 'Luo P', 'year': '2020', 'unstructured': 'Luo P, Qiu L, Liu Y, et al.. Metformin treatment was associated with ' 'decreased mortality in COVID-19 patients with diabetes in a ' 'retrospective analysis. Am J Trop Med Hyg. 2020, 103:69-72. ' '10.4269/ajtmh.20-0375', 'journal-title': 'Am J Trop Med Hyg'}, { 'key': 'ref13', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.lfs.2021.119371', 'article-title': 'Effects of metformin, insulin on COVID-19 patients with pre-existed ' 'type 2 diabetes: a multicentral retrospective study', 'volume': '275', 'author': 'Cheng X', 'year': '2021', 'unstructured': 'Cheng X, Xin S, Chen Y, et al.. Effects of metformin, insulin on ' 'COVID-19 patients with pre-existed type 2 diabetes: a multicentral ' 'retrospective study. Life Sci. 2021, 275:119371. ' '10.1016/j.lfs.2021.119371', 'journal-title': 'Life Sci'}, { 'key': 'ref14', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S2213-8587(20)30152-2', 'article-title': 'Practical recommendations for the management of diabetes in patients ' 'with COVID-19', 'volume': '8', 'author': 'Bornstein SR', 'year': '2020', 'unstructured': 'Bornstein SR, Rubino F, Khunti K, et al.. Practical recommendations for ' 'the management of diabetes in patients with COVID-19. Lancet Diabetes ' 'Endocrinol. 2020, 8:546-50. 10.1016/S2213-8587(20)30152-2', 'journal-title': 'Lancet Diabetes Endocrinol'}, { 'key': 'ref15', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.diabres.2020.108268', 'article-title': 'Is metformin ahead in the race as a repurposed host-directed therapy ' 'for patients with diabetes and COVID-19?', 'volume': '165', 'author': 'Singh AK', 'year': '2020', 'unstructured': 'Singh AK, Singh R. Is metformin ahead in the race as a repurposed ' 'host-directed therapy for patients with diabetes and COVID-19?. Diabetes ' 'Res Clin Pract. 2020, 165:108268. 10.1016/j.diabres.2020.108268', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': 'ref16', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.diabres.2020.108183', 'article-title': 'Metformin in COVID-19: a possible role beyond diabetes', 'volume': '164', 'author': 'Sharma S', 'year': '2020', 'unstructured': 'Sharma S, Ray A, Sadasivam B. Metformin in COVID-19: a possible role ' 'beyond diabetes. Diabetes Res Clin Pract. 2020, 164:108183. ' '10.1016/j.diabres.2020.108183', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': 'ref17', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/rmv.2146', 'article-title': 'Predictors of COVID-19 severity: a literature review', 'volume': '31', 'author': 'Gallo Marin B', 'year': '2021', 'unstructured': 'Gallo Marin B, Aghagoli G, Lavine K, et al.. Predictors of COVID-19 ' 'severity: a literature review. Rev Med Virol. 2021, 31:1-10. ' '10.1002/rmv.2146', 'journal-title': 'Rev Med Virol'}, { 'key': 'ref18', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.tim.2021.03.004', 'article-title': 'Therapeutic potential of metformin in COVID-19: reasoning for its ' 'protective role', 'volume': '29', 'author': 'Samuel SM', 'year': '2021', 'unstructured': 'Samuel SM, Varghese E, Büsselberg D. Therapeutic potential of metformin ' 'in COVID-19: reasoning for its protective role. Trends Microbiol. 2021, ' '29:894-907. 10.1016/j.tim.2021.03.004', 'journal-title': 'Trends Microbiol'}, { 'key': 'ref19', 'doi-asserted-by': 'publisher', 'DOI': '10.1210/clinem/dgae477', 'article-title': 'Renal protective effect of metformin in type 2 diabetes patients', 'author': 'Wang HH', 'year': '2024', 'unstructured': 'Wang HH, Lin SH, Hung SY, et al.. Renal protective effect of metformin ' 'in type 2 diabetes patients. J Clin Endocrinol Metab. 2024, 477. ' '10.1210/clinem/dgae477', 'journal-title': 'J Clin Endocrinol Metab'}, { 'key': 'ref20', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.biopha.2021.111454', 'article-title': 'Mechanism and application of metformin in kidney diseases: an update', 'volume': '138', 'author': 'Song A', 'year': '2021', 'unstructured': 'Song A, Zhang C, Meng X. Mechanism and application of metformin in ' 'kidney diseases: an update. Biomed Pharmacother. 2021, 138:111454. ' '10.1016/j.biopha.2021.111454', 'journal-title': 'Biomed Pharmacother'}, { 'key': 'ref21', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.dsx.2020.11.006', 'article-title': 'The effect of metformin consumption on mortality in hospitalized ' 'COVID-19 patients: a systematic review and meta-analysis', 'volume': '14', 'author': 'Lukito AA', 'year': '2020', 'unstructured': 'Lukito AA, Pranata R, Henrina J, Lim MA, Lawrensia S, Suastika K. The ' 'effect of metformin consumption on mortality in hospitalized COVID-19 ' 'patients: a systematic review and meta-analysis. Diabetes Metab Syndr. ' '2020, 14:2177-83. 10.1016/j.dsx.2020.11.006', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': 'ref22', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.dsx.2021.02.022', 'article-title': 'Metformin is associated with lower hospitalizations, mortality and ' 'severe coronavirus infection among elderly medicare minority patients ' 'in 8 states in USA', 'volume': '15', 'author': 'Ghany R', 'year': '2021', 'unstructured': 'Ghany R, Palacio A, Dawkins E, et al.. Metformin is associated with ' 'lower hospitalizations, mortality and severe coronavirus infection among ' 'elderly medicare minority patients in 8 states in USA. Diabetes Metab ' 'Syndr. 2021, 15:513-8. 10.1016/j.dsx.2021.02.022', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': 'ref23', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/cts.12897', 'article-title': 'Risk of metformin in patients with type 2 diabetes with COVID-19: a ' 'preliminary retrospective report', 'volume': '13', 'author': 'Gao Y', 'year': '2020', 'unstructured': 'Gao Y, Liu T, Zhong W, Liu R, Zhou H, Huang W, Zhang W. Risk of ' 'metformin in patients with type 2 diabetes with COVID-19: a preliminary ' 'retrospective report. Clin Transl Sci. 2020, 13:1055-9. ' '10.1111/cts.12897', 'journal-title': 'Clin Transl Sci'}, { 'key': 'ref24', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2201662', 'article-title': 'Randomized trial of metformin, ivermectin, and fluvoxamine for COVID-19', 'volume': '387', 'author': 'Bramante CT', 'year': '2022', 'unstructured': 'Bramante CT, Huling JD, Tignanelli CJ, et al.. Randomized trial of ' 'metformin, ivermectin, and fluvoxamine for COVID-19. N Engl J Med. 2022, ' '387:599-610. 10.1056/NEJMoa2201662', 'journal-title': 'N Engl J Med'}, { 'key': 'ref25', 'doi-asserted-by': 'publisher', 'DOI': '10.1053/j.ajkd.2022.10.012', 'article-title': 'Consensus recommendations for sick day medication guidance for people ' 'with diabetes, kidney, or cardiovascular disease: a modified Delphi ' 'process', 'volume': '81', 'author': 'Watson KE', 'year': '2023', 'unstructured': 'Watson KE, Dhaliwal K, Robertshaw S, et al.. Consensus recommendations ' 'for sick day medication guidance for people with diabetes, kidney, or ' 'cardiovascular disease: a modified Delphi process. Am J Kidney Dis. ' '2023, 81:564-74. 10.1053/j.ajkd.2022.10.012', 'journal-title': 'Am J Kidney Dis'}, { 'key': 'ref26', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.isci.2020.101425', 'article-title': 'ACE2, metformin, and COVID-19', 'volume': '23', 'author': 'Malhotra A', 'year': '2020', 'unstructured': 'Malhotra A, Hepokoski M, McCowen KC, Shyy JY. ACE2, metformin, and ' 'COVID-19. Iscience. 2020, 23:', 'journal-title': 'Iscience'}, { 'key': 'ref27', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ijms22052596', 'article-title': 'Multifaceted mechanisms of action of metformin which have been ' 'unraveled one after another in the long history', 'volume': '22', 'author': 'Kaneto H', 'year': '2021', 'unstructured': 'Kaneto H, Kimura T, Obata A, Shimoda M, Kaku K. Multifaceted mechanisms ' 'of action of metformin which have been unraveled one after another in ' 'the long history. Int J Mol Sci. 2021, 22:2596. 10.3390/ijms22052596', 'journal-title': 'Int J Mol Sci'}, { 'key': 'ref28', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.obmed.2020.100290', 'article-title': 'Metformin use is associated with reduced mortality rate from ' 'coronavirus disease 2019 (COVID-19) infection', 'volume': '19', 'author': 'Hariyanto TI', 'year': '2020', 'unstructured': 'Hariyanto TI, Kurniawan A. Metformin use is associated with reduced ' 'mortality rate from coronavirus disease 2019 (COVID-19) infection. Obes ' 'Med. 2020, 19:100290. 10.1016/j.obmed.2020.100290', 'journal-title': 'Obes Med'}, { 'key': 'ref29', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.diabet.2022.101359', 'article-title': 'Protection by metformin against severe COVID-19: an in-depth ' 'mechanistic analysis', 'volume': '48', 'author': 'Wiernsperger N', 'year': '2022', 'unstructured': 'Wiernsperger N, Al-Salameh A, Cariou B, Lalau JD. Protection by ' 'metformin against severe COVID-19: an in-depth mechanistic analysis. ' 'Diabetes Metab. 2022, 48:101359. 10.1016/j.diabet.2022.101359', 'journal-title': 'Diabetes Metab'}, { 'key': 'ref30', 'doi-asserted-by': 'publisher', 'DOI': '10.1210/en.2013-1002', 'article-title': 'Metformin inhibits vascular calcification in female rat aortic smooth ' 'muscle cells via the AMPK-eNOS-NO pathway', 'volume': '154', 'author': 'Cao X', 'year': '2013', 'unstructured': 'Cao X, Li H, Tao H, et al.. Metformin inhibits vascular calcification in ' 'female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. ' 'Endocrinol. 2013, 154:3680-9. 10.1210/en.2013-1002', 'journal-title': 'Endocrinol'}, { 'key': 'ref31', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(20)30305-6', 'article-title': 'Reducing mortality from 2019-nCoV: host-directed therapies should be an ' 'option', 'volume': '395', 'author': 'Zumla A', 'year': '2020', 'unstructured': 'Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from ' '2019-nCoV: host-directed therapies should be an option. Lancet. 2020, ' '395:e35-6. 10.1016/S0140-6736(20)30305-6', 'journal-title': 'Lancet'}], 'container-title': 'Cureus', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.cureus.com/articles/325967-does-the-consumption-of-metformin-correlate-with-a-reduction-in-mortality-among-patients-with-type-2-diabetes-and-covid-19-in-morocco', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2025, 1, 11]], 'date-time': '2025-01-11T17:55:48Z', 'timestamp': 1736618148000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://www.cureus.com/articles/325967-does-the-consumption-of-metformin-correlate-with-a-reduction-in-mortality-among-patients-with-type-2-diabetes-and-covid-19-in-morocco'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2025, 1, 11]]}, 'references-count': 31, 'URL': 'http://dx.doi.org/10.7759/cureus.77288', 'relation': {}, 'ISSN': ['2168-8184'], 'subject': [], 'published': {'date-parts': [[2025, 1, 11]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit